Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial (MM03)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01010243
Recruitment Status : Unknown
Verified May 2012 by Albrecht Reichle, University of Regensburg.
Recruitment status was:  Recruiting
First Posted : November 9, 2009
Last Update Posted : May 30, 2012
ClinAssess GmbH
Information provided by (Responsible Party):
Albrecht Reichle, University of Regensburg

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : October 2013
  Estimated Study Completion Date : October 2016